Bailard’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Bailard’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-811	Closed	-$33K	–	778
2022 Q2	$33K	Buy	+811	New	+$50.2K	﹤0.01%	678

Other funds holding NEXI

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

KHCM

Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Bailard's NEXI Position: Q3 2022 in Review

Bailard sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2022, closing a stake of 811 shares — an estimated $33K sold.

Bailard first reported a position in NEXI in Q2 2022 and held it in 1 quarter. The position peaked at $33K in Q2 2022. 38 funds tracked by Wall St. Rank hold NEXI as of Q3 2022.

Bailard reported no remaining NexImmune, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Bailard sold 811 NexImmune, Inc. Common Stock shares in Q3 2022, an estimated $33K.
Bailard first reported a position in NexImmune, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Bailard's NexImmune, Inc. Common Stock position peaked at $33K in Q2 2022.
38 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2022.

Based on Bailard's 13F filing for Q3 2022, filed 18 Oct 2022.